Alopexx   Report issue

For profit Phase 2
Founded: Concord MA United States (2011)

Organization Overview

First Clinical Trial
2013
NCT01874288
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Alopexx Oncology, LLC | Alopexx Pharmaceuticals, LLC | Alopexx Vaccine, LLC